Blackstone: Load Up Before It Recovers Its All-Time Highs (Rating Upgrade) (NYSE:BX)

Thos Robinson/Getty Images Entertainment Investors who held on to their positions in leading alternative asset manager Blackstone Inc. (NYSE:BX) have outperformed the S&P 500 (SPX) (SPY) since it bottomed out in December 2022. BX buyers nearly regained control of the pivotal $110 resistance level before sellers returned to digest its recent recovery amid market-wide profit-taking….

Read More

Vivid Seats: Taylor Swift Tours, Digital Marketing Improvements Imply Undervaluation. (NASDAQ:SEAT)

PM Images Vivid Seats Inc. (NASDAQ:SEAT) delivered quarterly market place orders growth, and offered a guidance increase. I think that further optimization of the performance of marketing campaigns, M&A, and organic growth from discounts strategy could accelerate FCF growth. Besides, further offerings like the Taylor Swift Eras tour could enhance the size of each order,…

Read More

Carvana Stock: It Is Not That Simple (NYSE:CVNA)

Joe Raedle Carvana Co. (NYSE:CVNA) is a $7.5-billion market cap Arizona-based firm that operates a US e-commerce platform for buying and selling used cars. Customers can research, inspect, finance, and purchase vehicles online, with options for delivery or pickup. If you take a quick look at the plethora of short-rated articles here on Seeking Alpha,…

Read More

KCCA: A Buy On Potential Tightening Of California Emission Regulations (NYSEARCA:KCCA)

tillsonburg/iStock via Getty Images While going through the performance of one of my smaller portfolio diversifiers, the KraneShares Global Carbon ETF (KRBN), I noticed that the KraneShares California Carbon Allowance ETF (NYSEARCA:KCCA), a sub-component of KRBN, had been performing much better than KRBN (Figure 1). Figure 1 – KCCA had been outperforming KBRN (Seeking Alpha)…

Read More

ADMA Biologics Stock: From Plasma To Profits With A Pinch Of Prudence (NASDAQ:ADMA)

Phynart Studio/E+ via Getty Images Introduction ADMA Biologics (NASDAQ:ADMA) is a commercial biopharmaceutical company that specializes in creating plasma-derived biologics for treating immunodeficient patients. Through its subsidiaries, ADMA BioManufacturing and ADMA BioCenters, the company produces and distributes FDA-approved products such as Bivigam and Nabi-HB. Originating from the acquisition of the Biotest Therapy Business Unit, ADMA…

Read More

5 Best CEFs To Buy This Month (August 2023)

Olivier Le Moal In this monthly article, we try to identify five closed-end funds (“CEFs”) that have a solid historical performance, pay high-enough distributions, and offer reasonable valuations at the current time. We also present a more diversified list of the top 10 funds. Author’s Note: This article is part of our monthly series that…

Read More

Rich Men North Of Richmond: A Bitcoin Anthem?

This is an opinion editorial by Spencer Nichols, Product Marketing Associate at Bitcoin Magazine and host of The Cosmic Bitcoin Podcast. Folk music artist Oliver Anthony took the internet by storm with a video of his song “Rich Men North of Richmond,” recorded in the woods near his off-grid home in Virginia, and has created…

Read More

Weekly Commentary: The Speculative Cycle

brijith vijayan/iStock via Getty Images While economists won’t ratchet Q3 growth estimates up to match the Atlanta Fed GDPNow’s 5.9%, forecasts will be moving higher. The Unemployment Rate is expected to remain unchanged for August, near a multi-decade low 3.5%. August Services PMI data point to some cooling, while stronger-than-expected (17-month high) New Home Sales…

Read More

Helios Towers: Solid Growth And Deleveraging Should Lead To Big Upside (OTCPK:HTWSF)

mahiruysal/E+ via Getty Images Helios Towers (OTCPK:HTWSF) is a telecommunication tower company focused on African and Middle-East regions. The business model of the tower companies is rather simple. Purchase a portfolio of towers, operate them efficiently and add more tenants on the towers, which elevates return on invested capital. While the stock has been sliding…

Read More

The West Is Losing Control Over The Gold Price

Lemon_tm/iStock via Getty Images An important change has unfolded in the global gold market. The East has been driving up the gold price, predominantly in late 2022 and the first months of 2023, breaking the West’s long-standing pricing power. Gold bazaar in Turkey. Pricing power in the gold market has recently shifted to the East….

Read More

Bond Sell-Off: An Opportune Moment

Andres Victorero Bond yields have surged to their highest level in over 15 years, propelled by resilient economic data and revised expectations for Federal Reserve policy. Nevertheless, the looming threat of subdued growth in 2024 suggests that bond yields are likely near their peak. This presents a potential opportunity for investors – add to duration…

Read More

Coty: Undervalued Beauty Powerhouse – Buy After Recent Share Price Slump (NYSE:COTY)

artisteer/iStock via Getty Images Introduction Coty (NYSE:COTY) concluded its fiscal year 2023 on a high note, marked by a robust Q4 performance and exceptional results for the entire year. The company’s journey toward financial recovery, exemplified by a reduction in debt, harmoniously aligned with its commitment to continuous innovation, resulting in the expansion of market…

Read More

AMETEK Stock: A Collection Of Niche Industrial Businesses (NYSE:AME)

gorodenkoff AMETEK (NYSE:AME) is a manufacturer of electronic instruments and electromechanical devices, and their business has been driven by both organic growth and acquisitions. AMETEK owns a collection of niche industrial companies and maintains significant market share in these niche industries, affording them tremendous pricing power. I believe that AMETEK’s performance-based, entrepreneurial culture makes them…

Read More

Managing Risk Through Alternative Investment Strategies

Henrik5000 Transcript Greg Bonnell: Markets have been increasingly pricing in a soft-landing scenario for the economy. But our guest today says that still means there’s going to be a landing of some sort, and investors may be too optimistic about the prospects for growth. Joining us now to discuss, Emin Baghramyan, lead of quantitative portfolio…

Read More

Spotify: Focus On User Growth (NYSE:SPOT)

Antony Jones/Getty Images Entertainment The month of August has been painful for stock investors, particularly for those with a large allocation toward tech stocks. High interest rates and the Fed’s ambivalence over when rate hikes will pause have forced many investors to rethink whether it’s worth it to be invested in stocks when risk-free bonds…

Read More

Agenus Stock: Immuno-Oncology Advancements Amidst Fiscal Pressures (NASDAQ:AGEN)

AmyKerk/iStock via Getty Images Introduction Agenus (NASDAQ:AGEN), a clinical-stage firm, specializes in therapies utilizing the body’s immune response to tackle cancer and infections. Through its subsidiaries, MiNK Therapeutics and SaponiQx, Agenus diversifies into adoptive cell therapies and vaccine adjuvants, respectively. Their strategy in Immuno-oncology (I-O) hinges on swift, innovative combinations. Agenus boasts a comprehensive lineup,…

Read More

EM Vs. DM Bonds: A Diverging Landscape

Viktor Aheiev The diverging performance of emerging markets local currency bonds in 2023 versus those in developed markets reflects the changing fundamental reality for fixed income investors. U.S. bond yields have been on an upwards trajectory in recent weeks, with the 10-year Treasury yield up nearly 100 basis points (bps) from its lowest level of…

Read More